Villanueva Rosa
Servicio de Psiquiatría y Salud Mental, Hospital Universitario La Paz, Hospital La Paz Institute for Health Research (IdiPAZ), Universidad Autónoma de Madrid, Madrid, Spain.
Front Psychiatry. 2025 Jan 7;15:1492415. doi: 10.3389/fpsyt.2024.1492415. eCollection 2024.
In this review, it is evaluated the progress in the application of stem cell therapy to ameliorate the symptoms of bipolar disorder, major depression, schizophrenia, and autism. These disorders are highly prevalent in clinical medicine and are responsible for high levels of psychosocial disability among patients. All of them share common biomedical features, such as complex and variable genetic substrates, significant susceptibility to environmental changes, and insufficient knowledge of their pathogenesis. In addition, the responsiveness of patients to pharmacological treatment is heterogeneous, and in some cases, no treatment is available. Therefore, the development of stem cell-based regenerative medicine and its possible combination with emerging therapeutic approaches that promote neural plasticity are expected to advance neuropsychiatry in the next few decades.
在本综述中,评估了干细胞疗法在改善双相情感障碍、重度抑郁症、精神分裂症和自闭症症状方面的应用进展。这些疾病在临床医学中极为普遍,导致患者出现高度的心理社会残疾。它们都具有共同的生物医学特征,如复杂多变的遗传基础、对环境变化的显著易感性以及对其发病机制的了解不足。此外,患者对药物治疗的反应具有异质性,在某些情况下甚至没有有效的治疗方法。因此,基于干细胞的再生医学的发展及其与促进神经可塑性的新兴治疗方法的可能结合,有望在未来几十年推动神经精神病学的发展。